• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫平滑肌肉瘤组织中CA125的表达

CA125 expression in the tissue of uterine leiomyosarcoma.

作者信息

Menczer Joseph, Schreiber Letizia, Berger Esther, Ben-Shem Erez, Golan Abraham, Levy Tally

机构信息

Department of Obstetrics and Gynecology, Wolfson Medical Center, Holon, Israel.

出版信息

Isr Med Assoc J. 2014 Nov;16(11):697-9.

PMID:25558698
Abstract

UNLABELLED

Background: Elevated serum levels of the epithelial marker CA125 are occasionally observed in leiomyosarcoma (LMS) patients.

OBJECTIVES

To assess the immunohistochemical expression of this marker in the tissue of LMS.

METHODS

The consecutive unselected records of all patients with LMS diagnosed during the period 1995-2012 were located and abstracted. After verification of the diagnosis, 4 μm unstained slides were prepared from each case for immunohistochemical staining for CA125. Sections of ovarian carcinoma known to express CA125 were used as positive controls.

RESULTS

We located 17 LMS patients from the period under study. Bleeding was the presenting symptom in 9 patients; the diagnosis was established prior to treatment in 11 patients. The tumor was in an advanced stage in 6 patients, and in 7 unstaged patients it was grossly confined to the uterus. Ten patients died within 14 months after the diagnosis. Serum CA125 levels prior to treatment were assessed in only 8 patients and were above normal limits (> 35 U/ml) in 3 of them. Two of the three with elevated serum levels were in stage III, and the third was an unstaged apparent stage I patient. None of the LMS tissue specimens demonstrated immunohistochemical expression of CA125.

CONCLUSIONS

CA125 was not immunohistochemically expressed in the tissue of any LMS tumors examined by us. The origin of elevated serum CA125 in some of these tumors is therefore not in its tissue and remains unknown.

摘要

未标记

背景:平滑肌肉瘤(LMS)患者偶尔会出现血清上皮标志物CA125水平升高的情况。

目的

评估该标志物在LMS组织中的免疫组化表达。

方法

查找并提取1995年至2012年期间确诊的所有LMS患者的连续未筛选记录。在确诊后,从每个病例中制备4μm未染色切片用于CA125免疫组化染色。已知表达CA125的卵巢癌切片用作阳性对照。

结果

我们在研究期间找到了17例LMS患者。9例患者以出血为首发症状;11例患者在治疗前确诊。6例患者肿瘤处于晚期,7例未分期患者肿瘤大体局限于子宫。10例患者在确诊后14个月内死亡。仅8例患者在治疗前评估了血清CA125水平,其中3例高于正常范围(>35 U/ml)。血清水平升高的3例患者中,2例处于III期,第3例是未分期的明显I期患者。所有LMS组织标本均未显示CA125的免疫组化表达。

结论

我们检查的任何LMS肿瘤组织中均未检测到CA125的免疫组化表达。因此,这些肿瘤中部分患者血清CA125升高并非源于肿瘤组织,其原因尚不清楚。

相似文献

1
CA125 expression in the tissue of uterine leiomyosarcoma.子宫平滑肌肉瘤组织中CA125的表达
Isr Med Assoc J. 2014 Nov;16(11):697-9.
2
The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.原发部位对平滑肌肉瘤结局的影响:子宫内与子宫外疾病临床病理差异的综述。
Am J Clin Oncol. 2013 Aug;36(4):368-74. doi: 10.1097/COC.0b013e318248dbf4.
3
Potential markers that complement expression of CA125 in epithelial ovarian cancer.可补充CA125在上皮性卵巢癌中表达的潜在标志物。
Gynecol Oncol. 2005 Nov;99(2):267-77. doi: 10.1016/j.ygyno.2005.06.040. Epub 2005 Aug 2.
4
Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA125.
Gynecol Oncol. 1999 Sep;74(3):499-501. doi: 10.1006/gyno.1999.5460.
5
Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.III期或IV期子宫内膜异位症中CA125、CA19-9和Ki-67的免疫组织化学分析:血清CA125水平与子宫内膜异位上皮细胞增殖之间的正相关关系。
Acta Obstet Gynecol Scand. 2000 Sep;79(9):771-6.
6
Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.子宫平滑肌肿瘤患者中Bcl-2受体表达:一项比较平滑肌瘤、恶性潜能不确定的子宫平滑肌肿瘤及平滑肌肉瘤的免疫组织化学分析
J Soc Gynecol Investig. 2004 Apr;11(3):187-91. doi: 10.1016/j.jsgi.2003.10.003.
7
"Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.“低度恶性平滑肌肉瘤”和子宫晚发复发性平滑肌肿瘤:这是一组经常被误诊的异质性肿瘤,与传统的子宫平滑肌肉瘤相比,总体预后良好。
Am J Surg Pathol. 2011 Nov;35(11):1626-37. doi: 10.1097/PAS.0b013e31822b44d2.
8
Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.血小板反应蛋白1(TSP 1)在子宫平滑肌肿瘤患者中的表达:一项免疫组织化学研究。
Gynecol Oncol. 2006 Oct;103(1):186-9. doi: 10.1016/j.ygyno.2006.02.023. Epub 2006 Apr 3.
9
Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).子宫平滑肌瘤、具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP)及子宫平滑肌肉瘤(LMS)患者的Ki-67表达情况。
Acta Obstet Gynecol Scand. 2004 Nov;83(11):1085-8. doi: 10.1111/j.0001-6349.2004.00502.x.
10
Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.评估子宫平滑肌肉瘤女性患者的预后参数。一项临床病理研究。
J Reprod Med. 2003 Feb;48(2):95-100.

引用本文的文献

1
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.CA125作为非恶性浆液性积液中的潜在生物标志物:诊断和预后考量
J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152.
2
The Role of CA125 and HE4 in Uterine Sarcomas: Beyond Diagnosis and Prognosis-A Systematic Review and Case Series from a Single Institution.CA125和HE4在子宫肉瘤中的作用:超越诊断和预后——来自单一机构的系统评价和病例系列研究
Cancers (Basel). 2025 Apr 27;17(9):1473. doi: 10.3390/cancers17091473.
3
Metastatic Uterine Leiomyosarcoma as a Rare and Sinister Cause of Respiratory Distress: A Case Report and Literature Review.
转移性子宫平滑肌肉瘤作为呼吸窘迫的罕见且严重病因:一例报告及文献综述
Cureus. 2023 May 16;15(5):e39101. doi: 10.7759/cureus.39101. eCollection 2023 May.
4
Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases.子宫平滑肌肉瘤复发和生存的预后因素:韩国单中心50例经验
Obstet Gynecol Sci. 2019 Mar;62(2):103-111. doi: 10.5468/ogs.2019.62.2.103. Epub 2019 Feb 12.
5
Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.血浆纤维蛋白原在子宫平滑肌肉瘤患者中的预后作用——一项多中心研究
Sci Rep. 2017 Nov 3;7(1):14474. doi: 10.1038/s41598-017-13934-8.
6
Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report.子宫平滑肌瘤伴 CA-125 升高合并上皮样血管肉瘤:一例报告
Gynecol Oncol Rep. 2017 May 5;21:1-4. doi: 10.1016/j.gore.2017.05.001. eCollection 2017 Aug.